Reversible mitral valve prolapse and mitral regurgitation in children with Graves' disease

Yueh-Ping Liu1, Wen-Yu Tsai, Jou-Kou Wang

  • 1Department of Pediatrics, National Taiwan University Hospital Taipei, Taiwan.

Insights

Mitral valve prolapse (MVP) with significant mitral regurgitation can affect children with hyperthyroidism, particularly Graves' disease. Cardiac symptoms resolved with thyroid treatment, indicating a good prognosis.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • The association between mitral valve prolapse (MVP) and hyperthyroidism is known in adults, but long-term prognosis in children with significant mitral regurgitation is unclear.
  • Graves' disease, an autoimmune cause of hyperthyroidism, requires careful cardiac evaluation in pediatric patients.

Observation:

  • Three pediatric patients with Graves' disease presented with significant mitral regurgitation murmurs and echocardiographic evidence of MVP.
  • Clinical manifestations included palpitations, exertional dyspnea, and exercise intolerance, with sinus tachycardia on ECG.
  • Exophthalmos was noted in two patients, with cardiac symptoms preceding ocular signs in one.

Findings:

  • Cardiac murmurs resolved in all patients following medical control of hyperthyroidism with antithyroid agents.
  • Follow-up echocardiography revealed normalization in one patient and mild mitral regurgitation with MVP in two.
  • These findings suggest a reversible nature of cardiac involvement in pediatric hyperthyroidism.

Implications:

  • Mitral valve prolapse and significant mitral regurgitation can occur in children with hyperthyroidism, especially Graves' disease.
  • Prompt diagnosis and effective management of hyperthyroidism are crucial for favorable cardiac outcomes in affected children.
  • This study highlights the importance of cardiac monitoring in pediatric hyperthyroidism and suggests a good prognosis with appropriate treatment.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...